keyword
https://read.qxmd.com/read/38510916/genexpert-mtb-rif-ultra-vs-unstimulated-interferon-%C3%AE-irisa-tb-for-the-diagnosis-of-tuberculous-pericarditis-in-a-tuberculosis-endemic-setting
#21
JOURNAL ARTICLE
Philippa Randall, Aliasgar Esmail, Lindsay Wilson, Edson Makambwa, Anil Pooran, Michele Tomasicchio, Keertan Dheda, Mpiko Ntsekhe
BACKGROUND: Tuberculous pericarditis (TBP) is a paucibacillary disease, where host biomarkers such as unstimulated interferon γ (IRISA-TB) have high diagnostic accuracy. However, DNA-based diagnostic tests (GeneXpert Ultra), more sensitive than an earlier versions, have recently become available. Given that the diagnosis of TBP is challenging, we performed a comparative diagnostic accuracy study comparing both assays. METHODS: We recruited 99 consecutive patients with suspected TBP in Cape Town, South Africa...
March 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38487729/identification-and-molecular-characterization-of-mycobacterium-bovis-dna-in-genexpert%C3%A2-mtb-rif-ultra-positive-culture-negative-sputum-from-a-rural-community-in-south-africa
#22
JOURNAL ARTICLE
Wynand J Goosen, Sashen Moodley, Giovanni Ghielmetti, Yumna Moosa, Thando Zulu, Theresa Smit, Leanie Kleynhans, Tanya J Kerr, Elizabeth M Streicher, Willem A Hanekom, Robin M Warren, Emily B Wong, Michele A Miller
This study investigated the presence of Mycobacterium bovis ( M. bovis ) DNA in archived human sputum samples previously collected from residents who reside adjacent to the M. bovis -endemic Hluhluwe-iMfolozi wildlife park, South Africa (SA). Sixty-eight sputum samples were GeneXpert MTB/RIF Ultra-positive for M. tuberculosis complex (MTBC) DNA but culture negative for M. tuberculosis . Amplification and Sanger sequencing of hsp65 and rpoB genes from DNA extracted from stored heat-inactivated sputum samples confirmed the presence of detectable amounts of MTBC from 20 out of the 68 sputum samples...
June 2024: One Health
https://read.qxmd.com/read/38487406/clinical-and-imaging-characteristics-of-smear-negative-pulmonary-tuberculosis-patients-a-comparative-study
#23
JOURNAL ARTICLE
Alem Alemayehu, Liya Wassie, Sebsib Neway, Samuel Ayele, Abraham Assefa, Kidist Bobosha, Beyene Petros, Rawleigh Howe
BACKGROUND: Prevalence surveys in Ethiopia indicate smear negative pulmonary tuberculosis (SNPTB) taking the major share of the overall TB burden. It has also been a diagnostic dilemma worldwide leading to diagnostic delays and difficulty in monitoring treatment outcomes. This study determines and compares the clinical and imaging findings in SNPTB and smear positive PTB (SPPTB). Methodology . A case-control study was conducted on 313 PTB (173 SNPTB) patients. Data and sputum samples were collected from consented patients...
2024: Pulmonary Medicine
https://read.qxmd.com/read/38486212/engagement-of-private-health-care-facilities-in-tb-management-in-lusaka-district-of-zambia-lessons-learned-and-achievements
#24
JOURNAL ARTICLE
Robert Hambwalula, Mary Kagujje, Innocent Mwaba, Dennis Musonda, David Singini, Lilungwe Mutti, Nsala Sanjase, Paul C Kaumba, Luunga M Ziko, Kevin M Zimba, Pauline Kasese-Chanda, Monde Muyoyeta
BACKGROUND: Globally, at least 3 million TB patients are missed every year. In Zambia, the TB treatment coverage increased from 66% in 2020 to 92% in 2022. Involvement of all levels of health care service delivery is critical to finding all the missing TB patients. METHODS: A survey was undertaken in 15 private facilities in Lusaka district of Zambia using a structured tool administered by project team and a district health team member. Data collected during the survey was analysed and results were used to determine the type of TB services that were offered as well as barriers and enablers to TB service provision...
March 14, 2024: BMC Public Health
https://read.qxmd.com/read/38482355/targeted-genome-sequencing-for-tuberculosis-drug-susceptibility-testing-in-south-africa-a-proposed-diagnostic-pipeline
#25
REVIEW
Tayarv J Bagratee, David J Studholme
In July 2023, the World Health Organization (WHO) began recommending targeted next-generation sequencing (tNGS), due to its ability to detect resistance to many drugs with a single test. In March 2023, South Africa further adopted the GeneXpert XDR cartridge, which detects mutations associated with resistance to second-line injectable drugs. Here, we consider the feasibility for implementing tNGS in South Africa, what such a facility might look like and the specific context of this upper-middle-income country...
2024: Access microbiology
https://read.qxmd.com/read/38482316/comparative-analysis-of-cbnaat-genexpert-and-ziehl-nielsen-staining-test-as-diagnostic-modalities-of-tuberculosis
#26
JOURNAL ARTICLE
Priyanka Yadav, Priyanka Mahour, Aditi Agarwal, Amit Garg
BACKGROUND: As centuries and millennia passed, tuberculosis remains the major health threat for millions of people. Due to this resurgence of tuberculosis, scientists around the globe have intensified their research efforts to curb down the transmission of this disease and that is the reason which led to the development of new and efficient diagnostic tools, one such being the rapid cartridge-based nucleic acid amplification test which can give the real-time results and that too in a short period of time...
January 2024: Journal of Family Medicine and Primary Care
https://read.qxmd.com/read/38476779/unveiling-neglected-pin-site-tuberculosis-an-uncommon-encounter-due-to-surgical-distal-end-radius-fracture-management-with-k-wires
#27
Hardik Patel, Dr Aditya Pundkar, Sandeep Shrivastava, Suyash Y Ambatkar, Saksham Goyal
In this case report, a 29-year-old man underwent surgery to treat a fracture to the left distal end of his radius using closed reduction and K-wire fixation. The patient was advised to follow up in the outpatient department after six weeks for cast and K-wire removal. Still, the patient failed to do so and was doing alternate day dressing of the K-wires. After six months he slipped and fell from his cot while sleeping, sustaining an injury to the left wrist. Initially, he developed a swelling over the wrist, which suddenly increased in size and ruptured...
February 2024: Curēus
https://read.qxmd.com/read/38476363/experiences-of-women-participating-in-a-human-papillomavirus-based-screen-triage-and-treat-strategy-for-cervical-cancer-prevention-in-malawi
#28
JOURNAL ARTICLE
Fan Lee, Shannon McGue, John Chapola, Wezzie Dunda, Jennifer H Tang, Margret Ndovie, Lizzie Msowoya, Victor Mwapasa, Jennifer S Smith, Lameck Chinula
OBJECTIVE: To explore the experiences of Malawian women who underwent a human papillomavirus (HPV)-based screen-triage-treat algorithm for cervical cancer (CxCa) prevention. This algorithm included GeneXpert® HPV testing of self-collected vaginal samples, visual inspection with acetic acid (VIA) and colposcopy for HPV-positive women, and thermal ablation of ablation-eligible women. METHOD: In-depth interviews were conducted with participants of a trial that evaluated the feasibility of a HPV-based screen-triage-treat algorithm among women living with HIV and HIV negative women in Lilongwe, Malawi...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38468858/advancements-in-lam-based-diagnostic-kit-for-tuberculosis-detection-enhancing-tb-diagnosis-in-hiv-negative-individuals
#29
JOURNAL ARTICLE
Man Gao, Qianhong Wu, Xinhong Wang, Xiuli Sun, Meng Li, Guanghong Bai
OBJECTIVE: The purpose of this study was to investigate the diagnostic value of urine lipoarabinomannan (LAM) detection based on chemiluminescence assay for pulmonary tuberculosis (PTB) and extrapulmonary tuberculosis (EPTB) in HIV-negative individuals. METHODS: A total of 215 patients and 37 healthy individuals were included according to inclusion and exclusion criteria, including 173 cases of PTB and 42 cases of EPTB. Sputum smears, sputum culture, TB-RNA, GeneXpert, and urine LAM results were obtained from all patients before treatment...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38451956/cervical-cancer-prevention-feasibility-of-self-sampling-and-hpv-testing-in-rural-and-urban-areas-of-bolivia-an-observational-study
#30
JOURNAL ARTICLE
Francesca Maria Carozzi, Ricardo Royder Yanez, Irene Paganini, Cristina Sani, Stefania Cannistrà, Marzia Matucci, Sandra von Borries, Silvia Traina
BACKGROUND: Cervical cancer is a major health problem in Latin America. In 2019, the Italian Agency for Development Cooperation (La Paz regional site) conducted a pilot study to estimate the prevalence of high-risk human papillomavirus (HPV) and the feasibility of HPV screening in Bolivia through self-sampling and portable and transportable laboratory instruments for HPV testing in urban and rural areas. METHODS: Women aged 20-65 years from La Paz (urban area), Toro Toro (rural area), and Acasio (rural area) were enrolled in local public health centers between Dec 1, 2019, and June 30, 2021...
2024: PloS One
https://read.qxmd.com/read/38438953/independent-clinic-based-evaluation-of-point-of-care-testing-for-the-screening-of-chlamydia-trachomatis-neisseria-gonorrhoea-and-trichomonas-vaginalis-in-women-at-risk-in-australia-guatemala-morocco-and-south-africa
#31
JOURNAL ARTICLE
Mark Shephard, Susan Matthews, Ranmini Kularatne, Kelly Andrewartha, Karel Blondeel, Christian Alvarez, Elsy Camey, Amina Hançali, Etienne Müller, Aurelie Haw, Hicham Oumzil, Daniel Golparian, Dorian E Ramirez, James Kiarie, Firdavs Kurbonov, Massimo Mirandola, Rosanna W Peeling, Ronaldo Silva, Soe Soe Thwin, Magnus Unemo, Igor Toskin
BACKGROUND: In 2018, the World Health Organization commenced a multi-country validation study of the Cepheid GeneXpert for a range of molecular-based point-of-care (POC) tests in primary care settings. One study arm focused on the evaluation of POC tests for screening 'women at risk' for chlamydia (CT), gonorrhoea (NG) and trichomonas (TV) in four countries - Australia, Guatemala, Morocco and South Africa. METHODS: Study participants completed a pre-test questionnaire which included demographics, clinical information and general questions on POC testing (POCT)...
March 4, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38435912/a-case-of-pulmonary-maltoma-camouflaged-within-invasive-pulmonary-aspergillosis
#32
Gurumurthy Thilagavathy, R K Sasankh, Arul Sekary, Niranjan Prabhu Ss
A 59-year-old non-smoking male, with a known case of COPD (chronic obstructive pulmonary disease), treated pulmonary tuberculosis with Category 1 antitubercular drugs (six-month regimen) and was admitted with repeated bouts of moderate haemoptysis (~60 mL/day) for three days. The patient had a history of self-limiting occasional mild haemoptysis (~20 mL) over three years. An HRCT chest revealed a left upper lobe fibro-cavitary lesion with an intracavitary mass (air crescent sign), adjacent pleural thickening and fibrosis...
January 2024: Curēus
https://read.qxmd.com/read/38419629/detection-of-mycobacterium-bovis-in-nasal-swabs-from-communal-goats-capra-hircus-in-rural-kwazulu-natal-south-africa
#33
JOURNAL ARTICLE
Deborah M Cooke, Charlene Clarke, Tanya J Kerr, Robin M Warren, Carmel Witte, Michele A Miller, Wynand J Goosen
Animal tuberculosis, caused by Mycobacterium bovis , presents a significant threat to both livestock industries and public health. Mycobacterium bovis tests rely on detecting antigen specific immune responses, which can be influenced by exposure to non-tuberculous mycobacteria, test technique, and duration and severity of infection. Despite advancements in direct M. bovis detection, mycobacterial culture remains the primary diagnostic standard. Recent efforts have explored culture-independent PCR-based methods for identifying mycobacterial DNA in respiratory samples...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38418963/clinic-based-evaluation-of-the-dual-xpert-ct-ng-assay-on-the-genexpert-system-for-screening-for-extragenital-chlamydial-and-gonococcal-infections-amongst-men-who-have-sex-with-men
#34
JOURNAL ARTICLE
Maddalena Cordioli, Lorenzo Gios, Anna Erbogasto, Massimo Mirandola, Angela Sandri, Valeska Padovese, Carlos Caceres, Silver Vargas, Karel Blondeel, Ronaldo Silva, James Kiarie, Firdavs Kurbonov, Rosanna W Peeling, Soe Soe Thwin, Daniel Golparian, Magnus Unemo, Igor Toskin
BACKGROUND: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections have increased globally. Asymptomatic infections represent a significant risk of long-term complications. Men who have sex with men (MSM) are disproportionally affected, underscoring the need to offer screening programmes to this population. CT/NG Point of Care Testing (POCT) constitutes a strategic tool to improve the continuum of STI care, however extensive real-life evaluations amongst at risk populations are lacking...
February 29, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38418947/quality-control-and-external-quality-assessment-for-the-independent-clinic-based-evaluation-of-point-of-care-testing-to-detect-chlamydia-trachomatis-neisseria-gonorrhoeae-and-trichomonas-vaginalis-in-eight-countries
#35
JOURNAL ARTICLE
Mark Shephard, Susan Matthews, Kelly Andrewartha, Wayne Dimech, Liza Cabuang, Christopher Barbara, Xiang-Sheng Chen, Maddalena Cordioli, Amina Hançali, Ting-Ting Jiang, Ranmini Kularatne, Stephanie Meli, Etienne Muller, Hicham Oumzil, Valeska Padovese, Angela Sandri, Silver Vargas, Graziella Zahra, Magnus Unemo, Karel Blondeel, Igor Toskin
BACKGROUND: Sexually transmitted infections caused by Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV) remain significant global health problems. The World Health Organization (WHO) has recently conducted a multi-faceted, multi-country validation study (ProSPeRo), which included an evaluation of the Xpert CT/NG and Xpert TV assays on the GeneXpert system (Cepheid, Sunnyvale, Ca., USA) in clinic-based settings across eight countries. To support the study, a training and quality management system was implemented and evaluated...
February 29, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38412542/cardiac-tuberculosis-a-case-series-from-ethiopia-italy-and-uganda-and-a-literature-review
#36
JOURNAL ARTICLE
Sergio Cotugno, Giacomo Guido, Giorgia Manco Cesari, Jerry Ictho, Peter Lochoro, James Amone, Francesco Vladimiro Segala, Elda De Vita, Rossana Lattanzio, Samuel Okori, Giuseppina De Iaco, Adisu Girma, Abata Sura, Eriballo Tariku Hessebo, Franco Balsemin, Giovanni Putoto, Luigi Ronga, Fabio Manenti, Enzo Facci, Annalisa Saracino, Francesco Di Gennaro
Extrapulmonary tuberculosis (TB) is estimated to account for up to 20% of active cases of TB disease, but its prevalence is difficult to ascertain because of the difficulty of diagnosis. Involvement of the heart is uncommon, with constrictive pericarditis being the most common cardiac manifestation. Diagnostic research for cardiac disease is frequently lacking, resulting in a high mortality rate. In addition to direct cardiac involvement, instances of cardiac events during antitubercular therapy are described...
February 27, 2024: American Journal of Tropical Medicine and Hygiene
https://read.qxmd.com/read/38408420/evaluation-of-genexpert-and-advanced-biological-laboratories-ultragene-hcv-diagnostic-detection-and-performance-against-roche-real-time-pcr-in-myanmar
#37
JOURNAL ARTICLE
Pedro Pisa, Constance Wose Kinge, Charles Chasela, Eula Mothibi, Yin Min Thaung, Hnin T Thwin, Nay M Aung, Kara W Chew, Malini M Gandhi, Cavenaugh Clint, Thomas Minior, Aye A Lwin, Morgan J Freiman, Khin P Kyi, Yi Y Sein, Fadzai Marange, Charles van der Horst, Sofiane Mohamed, Matthieu Barralon, Ian Sanne
BACKGROUND: Developing countries experience limited access to HCV laboratory tests for different reasons. Providing near to real-time HCV testing and results especially to at-risk populations including those in rural settings for timely initiation to treatment is key. Within a rural Myanmar setting, we compared HCV diagnostic detection and quantification of the GeneXpert, and Advanced Biological Laboratories UltraGene-HCV assays against the gold standard and reference method Roche real-time HCV in Myanmar...
February 12, 2024: Journal of Clinical Virology
https://read.qxmd.com/read/38390008/-drug-resistant-pulmonary-tuberculosis-at-maradi-regional-hospital-center-niger-2014-2018
#38
JOURNAL ARTICLE
Mahaman Laouali Harouna Amadou, Ibrahim Maman Lawan, Ousmane Abdoulaye, Abdoul Kadir Ibrahim Mamadou, Oumarou Amadou, Hassane Boureima, Biraima Ahamadou, Nouhou Hama Aghali, Nana Hadiza Abdourahamane Maifada, Abdoulaziz Kabirou Amoussa, Chaibou Maidakouale
AIM OF STUDY: To describe the clinical, therapeutic and evolutionary profile of patients followed for rifampicin-resistant pulmonary tuberculosis (RR-TB) at the Regional Hospital Centre (RHC) of Maradi (Niger) from 2014 to 2018. METHODS: We conducted a retrospective and descriptive study based on the records of patients followed for Multidrug-resistant tuberculosis (MDR-TB) between January 1, 2014 and June 30, 2018 at the resistant tuberculosis management unit in Maradi (Niger)...
December 31, 2023: Med Trop Sante Int
https://read.qxmd.com/read/38384275/a-comparative-study-of-massarray-and-genexpert-assay-in-detecting-rifampicin-resistance-in-tuberculosis-patients-clinical-specimens
#39
JOURNAL ARTICLE
Ruixia Liang, Jiankang Li, Yue Zhao, Haoran Qi, Shengjuan Bao, Fen Wang, Hongfei Duan, Hairong Huang
OBJECTIVES: Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a potent tool for detecting drug resistance in tuberculosis (TB); however, concerns about its reliability have been raised. In this study, we assessed the reliability of MassARRAY (Sequenom, Inc.), which is a MALDI-TOF MS-based method, by comparing it to the well-established GeneXpert assay (Cepheid) as a reference method. METHODS: A retrospective study was conducted using laboratory data retrieved from Henan Chest Hospital (Zhengzhou, China)...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38381893/evaluation-of-the-genexpert-mtb-rif-to-diagnose-tuberculosis-in-a-public-health-laboratory
#40
JOURNAL ARTICLE
Mohanna Damasceno Arbués, Maria Lúcia Rosa Rossetti
OBJECTIVES: To evaluate the performance of geneXpert MTB/Rif versus conventional methods (bacilloscopy and culture) in the diagnosis of tuberculosis in a Central Public Health Laboratory (LACEN, Tocantins), Northern Brazil. METHODS: Retrospective study, with information from 1,973 suspected cases of tuberculosis from patients treated from January 2015 to December 2020. RESULTS: From the culture (reference standard), the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the geneXpert MTB/Rif were 100%, 97%, 74%, 100%, and 97%, respectively, against 85%, 98%, 80%, 98%, and 97% of bacilloscopy...
2024: Revista de Saúde Pública
keyword
keyword
53912
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.